A new study published in the Journal of the American Board of Family Medicine found that patients with gastroesophageal ...
Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal (GI) diseases, today announced its ...
A health insurance dispute is preventing a North Carolina man from getting a cancer drug his doctors say is necessary.